6 月 26 日,百济神州举行了投资者研发日活动。会上,百济神州高层领导团队、资深研发负责人以及行业意见领袖,从多维度阐述了百济神州的科学战略和执行能力。百济神州正处于发展的关键时期,目前拥有 40 多款处于临床开发和商业化阶段的产品。未来 18 个月内,预计将迎来 20 项里程碑进展。研发战略据百济神州全球研发负责人汪来博士介绍,公司的整体研发战略包括四个方面:1)在重点疾病领域开发深厚且具有...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.